Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-11-21FDA Approved: VENLAFAXINE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved the original generic application for venlafaxine from Cadila Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial [Phase 4]
A double-blind randomized placebo-controlled Phase 4 trial evaluating kava for generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD) [Phase 3]
Phase 3 trial update for EDG004 in adults with generalized anxiety disorder; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway [Phase 2]
A Phase 2 trial evaluating the effectiveness of Cognitive Behavioral Therapy for child anxiety disorders conducted in community clinics in N…
-
FDA label_change · 2018-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for venlafaxine hydrochloride filed by Macleods Pharmaceuticals Limited. The approval is associated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-24Clinical Trial Update: Worry Exposure for Generalized Anxiety Disorder [NA]
The clinical trial 'Worry Exposure for Generalized Anxiety Disorder' sponsored by the University of Texas at Austin has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder [NA]
The clinical trial evaluating cognitive-behavioral treatment and interpretation modification training for adults with Generalized Anxiety Di…
-
FDA approval · 2018-07-19FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depr…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Short-Term Efficacy and Mechanisms of Change of a Worry Postponement Intervention for Generalized Anxiety Disorder [NA]
The study evaluates a worry postponement intervention for Generalized Anxiety Disorder and reports on its short-term efficacy and potential …
-
FDA approval · 2018-06-12FDA Approved: PAROXETINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved the original abbreviated new drug application for paroxetine hydrochloride hemihydrate from Rhodes Pharmaceuticals, establishin…
-
FDA approval · 2018-05-03FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (APNAR PHARMA LP)
The FDA approves an original ANDA for buspirone hydrochloride from APNAR PHARMA LP, enabling a generic version of buspirone to be marketed.
-
CLINICAL_TRIALS research · 2018-04-27Clinical Trial Update: Rumination Focus Cognitive Behavior Therapy [NA]
Clinical trial update on Rumination Focus Cognitive Behavior Therapy for depression and anxiety disorders. The current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Pilot Study of Virtual Reality for Providing Exposure Therapy to Children [NA]
A pilot study evaluating virtual reality exposure therapy for children with Generalized Anxiety Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1
This completed clinical trial evaluated the use of lived experience to improve mental health diagnosis. It covered conditions including depr…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat [NA]
Clinical trial assessing extended-release quetiapine as an adjunct to cognitive behavioral therapy for major depressive disorder and general…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder [NA]
Clinical trial comparing cognitive, behavioral, and cognitive-behavioral therapy for Generalized Anxiety Disorder has completed with posted …
-
FDA approval · 2017-12-19FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2017-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Internet-Based Exposure Therapy Vs. Stress-Management Training for Worry [NA]
A completed trial comparing internet-based exposure therapy with stress-management training for excessive worry.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety [NA]
A completed clinical trial evaluating visual mismatch negativity in attention bias modification treatment for anxiety. The study targeted so…
-
CLINICAL_TRIALS research · 2017-11-01Clinical Trial Update: Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression [NA]
A clinical trial update describing a simplified cognitive behavioral therapy approach for generalized anxiety disorder and major depressive …
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders [NA]
This clinical trial evaluating computer-assisted cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorde…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Therapeutic Massage for Generalized Anxiety Disorder [Phase 1, Phase 2]
The clinical trial update indicates completion of Phase 1 and Phase 2 studies evaluating therapeutic massage for Generalized Anxiety Disorde…
-
FDA approval · 2017-10-11FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)
FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
This completed clinical trial update examines how generalized anxiety disorder and social anxiety disorder influence information processing …